Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...
Reexamination Certificate
2006-09-26
2006-09-26
Vogel, Nancy (Department: 1636)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Animal cell, per se, expressing immunoglobulin, antibody, or...
C435S320100, C435S252300
Reexamination Certificate
active
07112439
ABSTRACT:
The present invention provides a dual expression vector, and methods for its use, for the expression and secretion of a full-length polypeptide of interest in eukaryotic cells, and a soluble domain or fragment of the polypeptide in bacteria. When expressed in bacteria, transcription from a bacterial promoter within a first intron and termination at the stop codon in a second intron results in expression of a fragment of the polypeptide, e.g., a Fab fragment, whereas in mammalian cells, splicing removes the bacterial regulatory sequences located in the two introns and generates the mammalian signal sequence, allowing expression of the full-length polypeptide, e.g., IgG heavy or light chain polypeptide. The dual expression vector system of the invention can be used to select and screen for new monoclonal antibodies, as well as to optimize monoclonal antibodies for binding to antigenic molecules of interest.
REFERENCES:
patent: 4703004 (1987-10-01), Hopp et al.
patent: 5506121 (1996-04-01), Skerra et al.
Abrahmsen et al., “Secretion of heterologous gene products to the culture medium ofEscherichia coli”, Nucl. Acids Res. 14:7487-7500 (1986).
Amann et al., “Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes inEscherichia coli”, Gene 25:167-178 (1983).
Barbas et al., “Assembly of combinatorial antibody libraries on phage surfaces: the gene III site”, Proc. Natl. Acad. Sci. USA 88:7978-7982 (1991).
Bennett et al., “Nucleotide sequence of region preceding trp mRNA initiation site and its role in promoter and operator function”, Proc. Natl. Acad. Sci. USA 73:2351-2355 (1976).
Benoist and Chambon, “In vivosequence requirements of the SV40 early promoter region”, Nature 290:304-310 (1981).
Bird et al., “Single-chain antigen-binding proteins”, Science 242:423-426 (1988).
Bornhorst and Falke, “Purification of proteins using polyhistidine affinity tags”, Meth. Enzymol. 326:245-254 (2000).
Brinster et al., “Regulation of metallothionein—thymidine kinase fusion plasmids injected into mouse eggs”, Nature 296:39-42 (1982).
Brizzard et al., “Immunoaffinity purification of FLAG® epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution”, BioTechniques 16:730-735 (1994).
Burks et al., “GenBank”, Nucl. Acids Res. 19:2227-2230 (1991).
Carter et al., “Humanization of an anti-p185HER2 antibody for human cancer therapy”, Proc. Natl. Acad. Sci. USA 89:4285-4289 (1992).
Chothia et al., “Structural determinants in the sequences of immunoglobulin variable domain”, J. Mol. Biol. 278:457-479 (1998).
Clynes et al., “Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets”, Nature Med. 6:443-446 (2000).
DeBoer et al., “The tac promoter: a functional hybrid derived from the trp lac promoters”, Proc. Natl. Acad. Sci. USA 80:21-25 (1983).
Eikmanns et al., “A family ofCorynebacterium glutamicum/Escherichia colishuttle vectors for cloning, controlled gene expression, and promoter probing”, Gene 102:93-98 (1991).
Evan et al., “Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product”, Mol. Cell. Biol. 5:3610-3616 (1985).
Friedrich and Soriano, “Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice”, Genes Dev. 5:1513-1523 (1991).
Gardener et al., “The complete nucleotide sequence of an infectious clone of cauliflower mosiac virus by M13mp7 shotgun sequencing”, Nucl. Acids Res. 9:2871-2878 (1981).
Geissendörfer and Hillen, “Regulated expression of heterologous genes inBacillus subtilisusing the Tn10 encoded tet regulatory elements”, Appl. Microbiol. Biotechnol. 33:657-663 (1990).
Ghetie and Ward, Transcytosis and catabolism of antibody, Immunol. Res. 25:97-113 (2002).
Gilbert and Maxam, “The nucleotide sequence of thelacoperator”, Proc. Natl. Acad. Sci. USA 70:3581-3584 (1973).
Gilbert and Villa-Komaroff, “Useful proteins from recombinant bacteria”, Scientific American 242:74-94 (1980).
Gossen and Bujard, “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters”, Proc. Natl. Acad. Sci. USA 89:5547-5551 (1992).
Hegedus et al., “A series of broad host range shuttle vectors for constitutive and inducible expression of heterologous proteins in insect cell lines” Gene 207:241-249 (1998).
Herrera-Estrella et al., “Expression of chimaeric genes transferred into plant cells using a Ti-plasmid-derived vector”, Nature 303:209-213 (1983).
Herrera-Estrella et al., “Light-inducible and chloroplast-associated expression of a chimaeric gene introduced intoNicotiana tabacumusing a Ti plasmid vector”, Nature 310:115-120 (1984).
Hobom et al., “OmpA fusion proteins for presentation of foreign antigens on the bacterial outer membrane”, Dev. Biol. Stand. 84:255-262.
Hoffman and Wright, “Fusions of secreted proteins to alkaline phosphatase: an approach for studying protein secretion” Proc. Natl. Acad. Sci. USA 82:5107-5111 (1985).
Hoogenboom et al., “Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains”, Nucleic Acids Res. 19:4133-4137 (1991).
Horii et al., “Organization of the recA gene ofEscherichia coli”, Proc. Natl. Acad. Sci. USA 77:313-317 (1980).
Hudson and Kortt, “High avidity scFv multimers; diabodies and triabodies”, J. Immunol. Meth. 231:177-189 (1999).
Huse et al., “Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda”, Science 246:1275-1281 (1989).
Huse et al., “Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. 1989”, Biotechnology 24:517-523 (1992).
Huston et al., “Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced inEscherichia coli”, Proc. Natl. Acad. Sci. USA 85:5879-5883 (1988).
Johnson et al. , “Refolding, purification, and characterization of human erythropoietin binding protein produced inEscherichia coli”, Protein Expr. Purif. 7:104-113 (1996).
Johnson et al., “Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus”, J. Infect. Dis. 176:1215-1224 (1997).
Jones et al., “Replacing the complementarity-determining regions in a human antibody with those from a mouse”, Nature 321:522-525 (1986).
Kadonaga et al., “The role of the beta-lactamase signal sequence in the secretion of proteins ofEscherichia coli”, J. Biol. Chem. 259:2149-2154 (1984).
Kaiser et al., “Many random sequences functionally replace the secretion signal sequence of yeast invertase”, Science 235:312-317 (1987).
Kang et al., “Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces”, Proc. Natl. Acad. USA 88:4363-4366 (1991).
Knappik and Plückthun, “An improved affinity tag based on the FLAG® peptide for the detection and purification of recombinant antibody fragments”, BioTechniques 17:754-761 (1994).
Kozak, “Structural features in eukaryotic mRNAs that modulate the initiation of translation”, J. Biol. Chem. 266:19867-19870 (1991).
Kutemeier et al., “Assembly of humanized antibody genes from synthetic oligonucleotides using a single-round PCR”, BioTechniques 17:242-246 (1994).
Lo et al., “Bacillus subtilisbeta-1,4-endoglucanase products from intact and truncated genes are secreted into the extracellular medium byEscherichia coli”, Appl. Environ. Microbi
Huang Ling
Johnson Leslie Sydnor
Jones Day
MacroGenics, Inc.
Vogel Nancy
LandOfFree
Dual expression vector system for antibody expression in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dual expression vector system for antibody expression in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dual expression vector system for antibody expression in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3607807